Rodin secures $12.9 million in series A

Epigenetics company Rodin Therapeutics Inc. (Cambridge, Mass.) secured $12.9 million in a series A round co-led by existing investors Atlas Venture and Johnson & Johnson Development Corp. (JJDC), the ...